loadpatents
name:-0.024945974349976
name:-0.024671077728271
name:-0.0017898082733154
Breslin; Henry J. Patent Filings

Breslin; Henry J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Breslin; Henry J..The latest application filed is for "novel compounds as opioid receptor modulators".

Company Profile
1.23.18
  • Breslin; Henry J. - Lansdale PA
  • Breslin; Henry J - Lansdale PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds as opioid receptor modulators
Grant 10,213,415 - Breslin , et al. Feb
2019-02-26
Novel Compounds As Opioid Receptor Modulators
App 20180325870 - BRESLIN; HENRY J. ;   et al.
2018-11-15
Azaquinazoline inhibitors of Atypical protein Kinase C
Grant 9,914,730 - Breslin , et al. March 13, 2
2018-03-13
Azaquinazoline inhibitors of atypical protein kinase C
Grant 9,896,446 - Breslin , et al. February 20, 2
2018-02-20
Compounds as opioid receptor modulators
Grant 9,700,542 - Breslin , et al. July 11, 2
2017-07-11
Macrocyclic Compounds As Alk, Fak And Jak2 Inhibitors
App 20170027948 - Breslin; Henry J. ;   et al.
2017-02-02
Macrocyclic compounds as ALK, FAK and JAK2 inhibitors
Grant 9,487,529 - Breslin , et al. November 8, 2
2016-11-08
Azaquinazoline Inhibitors of Atypical Protein Kinase C
App 20160102094 - Breslin; Henry J. ;   et al.
2016-04-14
Novel Compounds As Opioid Receptor Modulators
App 20160030393 - BRESLIN; HENRY J. ;   et al.
2016-02-04
Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders
Grant 9,238,656 - Breslin , et al. January 19, 2
2016-01-19
Compounds as opioid receptor modulators
Grant 9,205,076 - Breslin , et al. December 8, 2
2015-12-08
Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders
App 20140350011 - Breslin; Henry J. ;   et al.
2014-11-27
Phenoxy-substituted pyrimidines as opioid receptor modulators
Grant 8,895,573 - Coats , et al. November 25, 2
2014-11-25
Novel Compounds As Opioid Receptor Modulators
App 20140256779 - Breslin; Henry J. ;   et al.
2014-09-11
Compounds as opioid receptor modulators
Grant 8,772,325 - Breslin , et al. July 8, 2
2014-07-08
Azaquinazoline Inhibitors of Atypical Protein Kinase C
App 20140113882 - Breslin; Henry J. ;   et al.
2014-04-24
Phenoxy-substituted Pyrimidines As Opioid Receptor Modulators
App 20140066422 - Coats; Steven J. ;   et al.
2014-03-06
Novel Compounds As Opioid Receptor Modulators
App 20140039024 - BRESLIN; HENRY J. ;   et al.
2014-02-06
Macrocyclic Compounds as ALK, FAK and JAK2 Inhibitors
App 20140031351 - Breslin; Henry J. ;   et al.
2014-01-30
Compounds as opioid receptor modulators
Grant 8,609,709 - Breslin , et al. December 17, 2
2013-12-17
Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors
Grant 8,552,186 - Ahmed , et al. October 8, 2
2013-10-08
Pyrrolotriazines as ALK and JAK2 inhibitors
Grant 8,471,005 - Breslin , et al. June 25, 2
2013-06-25
Novel Compounds As Opioid Receptor Modulators
App 20130090478 - BRESLIN; HENRY J. ;   et al.
2013-04-11
Compounds as opioid receptor modulators
Grant 8,344,011 - Breslin , et al. January 1, 2
2013-01-01
Pyrrolotriazines As Alk And Jak2 Inhibitors
App 20120028919 - Breslin; Henry J. ;   et al.
2012-02-02
Novel Compounds As Opioid Receptor Modulators
App 20100324051 - Breslin; Henry J. ;   et al.
2010-12-23
Compounds as opioid receptor modulators
Grant 7,786,158 - Breslin , et al. August 31, 2
2010-08-31
Compounds as opioid receptor modulators
Grant 7,741,356 - Breslin , et al. June 22, 2
2010-06-22
Piperidines as opioid receptor modulators
Grant 7,659,402 - Breslin , et al. February 9, 2
2010-02-09
Novel Compounds As Opioid Receptor Modulators
App 20080096888 - Breslin; Henry J. ;   et al.
2008-04-24
Compounds as opioid receptor modulators
Grant 7,202,381 - Breslin , et al. April 10, 2
2007-04-10
Compounds as opioid receptor modulators
Grant 7,041,681 - Breslin , et al. May 9, 2
2006-05-09
Novel compounds as opioid receptor modulators
App 20060030558 - Breslin; Henry J. ;   et al.
2006-02-09
Novel compounds as opioid receptor modulators
App 20050203143 - Breslin, Henry J. ;   et al.
2005-09-15
Novel compounds as opioid receptor modulators
App 20050187252 - Breslin, Henry J. ;   et al.
2005-08-25
Novel compounds as opioid receptor modulators
App 20040010014 - Breslin, Henry J. ;   et al.
2004-01-15
Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2-(thi)ones
Grant 5,371,079 - Kukla , et al. * December 6, 1
1994-12-06
Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones
Grant 5,270,464 - Kukla , et al. December 14, 1
1993-12-14
Guanidine derivatives, compositions and use
Grant 5,268,373 - Breslin , et al. December 7, 1
1993-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed